2019 ASCO Annual Meeting June 2, 2019 from 8:00 AM to 11:00 AM CDT Presenter: Benjamin M. Ellingson, PhD, MS. University of California Los Angeles Supporting Materials Quantitative radiographic analysis of phase II and III trials in recurrent glioblastoma treated with VB-111 with or without bevacizumab or bevacizumab monotherapy 5.7 MB
Quantitative radiographic analysis of phase II and III trials in recurrent glioblastoma treated with VB-111 with or without bevacizumab or bevacizumab monotherapy 5.7 MB